4//SEC Filing
Bermingham Nessan 4
Accession 0001209191-17-065659
CIK 0001652130other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 4:07 PM ET
Size
5.4 KB
Accession
0001209191-17-065659
Insider Transaction Report
Form 4
Bermingham Nessan
DirectorPresident & CEO10% Owner
Transactions
- Award
Stock Option (right to buy)
2017-12-12+292,500→ 292,500 totalExercise: $18.30Exp: 2027-12-11→ Common Stock (292,500 underlying)
Footnotes (1)
- [F1]This option was granted on December 12, 2017 with respect to 292,500 shares of Common Stock, with 25% vesting on December 12, 2018 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001377759
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 4:07 PM ET
- Size
- 5.4 KB